WO2007036491A1 - Procede de production d'acides carboxyliques alpha-substitues - Google Patents
Procede de production d'acides carboxyliques alpha-substitues Download PDFInfo
- Publication number
- WO2007036491A1 WO2007036491A1 PCT/EP2006/066641 EP2006066641W WO2007036491A1 WO 2007036491 A1 WO2007036491 A1 WO 2007036491A1 EP 2006066641 W EP2006066641 W EP 2006066641W WO 2007036491 A1 WO2007036491 A1 WO 2007036491A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- formula
- carboxylic acid
- branched
- alkyl
- chlorine
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 41
- 150000001735 carboxylic acids Chemical class 0.000 title abstract description 15
- 238000004519 manufacturing process Methods 0.000 title abstract description 5
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims abstract description 28
- 150000001733 carboxylic acid esters Chemical class 0.000 claims abstract description 5
- 238000006243 chemical reaction Methods 0.000 claims description 19
- 150000001875 compounds Chemical class 0.000 claims description 19
- 238000002360 preparation method Methods 0.000 claims description 19
- 239000000460 chlorine Substances 0.000 claims description 18
- 229910052801 chlorine Inorganic materials 0.000 claims description 18
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 15
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 13
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 13
- 229910052794 bromium Inorganic materials 0.000 claims description 13
- 125000004122 cyclic group Chemical group 0.000 claims description 12
- 229910052744 lithium Inorganic materials 0.000 claims description 9
- 125000001424 substituent group Chemical group 0.000 claims description 9
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 7
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical group II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 6
- 239000008139 complexing agent Substances 0.000 claims description 6
- 125000005265 dialkylamine group Chemical group 0.000 claims description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 5
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims description 5
- 125000003118 aryl group Chemical group 0.000 claims description 5
- 150000007942 carboxylates Chemical class 0.000 claims description 5
- 125000004663 dialkyl amino group Chemical group 0.000 claims description 5
- 125000004986 diarylamino group Chemical group 0.000 claims description 5
- 239000001257 hydrogen Substances 0.000 claims description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims description 5
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 5
- 125000004001 thioalkyl group Chemical group 0.000 claims description 5
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 4
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 claims description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 3
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 3
- 239000006184 cosolvent Substances 0.000 claims description 3
- 238000001212 derivatisation Methods 0.000 claims description 3
- 230000032050 esterification Effects 0.000 claims description 3
- 238000005886 esterification reaction Methods 0.000 claims description 3
- 229910052736 halogen Inorganic materials 0.000 claims description 3
- 150000002367 halogens Chemical class 0.000 claims description 3
- 229910052700 potassium Inorganic materials 0.000 claims description 3
- 239000011591 potassium Substances 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- 239000002841 Lewis acid Substances 0.000 claims description 2
- 150000007517 lewis acids Chemical class 0.000 claims description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims 1
- 229910052740 iodine Inorganic materials 0.000 claims 1
- 239000011630 iodine Substances 0.000 claims 1
- 230000002152 alkylating effect Effects 0.000 abstract 1
- -1 allyl halides Chemical class 0.000 description 32
- 239000002585 base Substances 0.000 description 23
- 150000003254 radicals Chemical class 0.000 description 14
- 230000015572 biosynthetic process Effects 0.000 description 7
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 7
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- 125000004432 carbon atom Chemical group C* 0.000 description 6
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 6
- GUVUOGQBMYCBQP-UHFFFAOYSA-N dmpu Chemical compound CN1CCCN(C)C1=O GUVUOGQBMYCBQP-UHFFFAOYSA-N 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- UOORRWUZONOOLO-OWOJBTEDSA-N (E)-1,3-dichloropropene Chemical compound ClC\C=C\Cl UOORRWUZONOOLO-OWOJBTEDSA-N 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 239000007858 starting material Substances 0.000 description 5
- UOORRWUZONOOLO-UHFFFAOYSA-N telone II Natural products ClCC=CCl UOORRWUZONOOLO-UHFFFAOYSA-N 0.000 description 5
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 4
- 230000029936 alkylation Effects 0.000 description 4
- 238000005804 alkylation reaction Methods 0.000 description 4
- PPXUHEORWJQRHJ-UHFFFAOYSA-N ethyl isovalerate Chemical compound CCOC(=O)CC(C)C PPXUHEORWJQRHJ-UHFFFAOYSA-N 0.000 description 4
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 230000005595 deprotonation Effects 0.000 description 3
- 238000010537 deprotonation reaction Methods 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical class CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 2
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 2
- 150000005840 aryl radicals Chemical class 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 229940043279 diisopropylamine Drugs 0.000 description 2
- 239000012039 electrophile Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- OVEHNNQXLPJPPL-UHFFFAOYSA-N lithium;n-propan-2-ylpropan-2-amine Chemical compound [Li].CC(C)NC(C)C OVEHNNQXLPJPPL-UHFFFAOYSA-N 0.000 description 2
- DVSDBMFJEQPWNO-UHFFFAOYSA-N methyllithium Chemical compound C[Li] DVSDBMFJEQPWNO-UHFFFAOYSA-N 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- NHKJPPKXDNZFBJ-UHFFFAOYSA-N phenyllithium Chemical compound [Li]C1=CC=CC=C1 NHKJPPKXDNZFBJ-UHFFFAOYSA-N 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000007086 side reaction Methods 0.000 description 2
- 125000005490 tosylate group Chemical group 0.000 description 2
- 150000008648 triflates Chemical class 0.000 description 2
- PPKPKFIWDXDAGC-NSCUHMNNSA-N (e)-1,2-dichloroprop-1-ene Chemical compound C\C(Cl)=C/Cl PPKPKFIWDXDAGC-NSCUHMNNSA-N 0.000 description 1
- NOPVMHYFCPFLOH-HWKANZROSA-N (e)-5-chloro-2-propan-2-ylpent-4-enoic acid Chemical compound CC(C)C(C(O)=O)C\C=C\Cl NOPVMHYFCPFLOH-HWKANZROSA-N 0.000 description 1
- 125000005919 1,2,2-trimethylpropyl group Chemical group 0.000 description 1
- 125000005918 1,2-dimethylbutyl group Chemical group 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- 125000004973 1-butenyl group Chemical group C(=CCC)* 0.000 description 1
- 125000006218 1-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000006039 1-hexenyl group Chemical group 0.000 description 1
- 125000006023 1-pentenyl group Chemical group 0.000 description 1
- 125000004343 1-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000006017 1-propenyl group Chemical group 0.000 description 1
- VFTFKUDGYRBSAL-UHFFFAOYSA-N 15-crown-5 Chemical compound C1COCCOCCOCCOCCO1 VFTFKUDGYRBSAL-UHFFFAOYSA-N 0.000 description 1
- FALCMQXTWHPRIH-UHFFFAOYSA-N 2,3-dichloroprop-1-ene Chemical compound ClCC(Cl)=C FALCMQXTWHPRIH-UHFFFAOYSA-N 0.000 description 1
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
- 125000006176 2-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000006040 2-hexenyl group Chemical group 0.000 description 1
- NJBCRXCAPCODGX-UHFFFAOYSA-N 2-methyl-n-(2-methylpropyl)propan-1-amine Chemical compound CC(C)CNCC(C)C NJBCRXCAPCODGX-UHFFFAOYSA-N 0.000 description 1
- 125000004493 2-methylbut-1-yl group Chemical group CC(C*)CC 0.000 description 1
- 125000005916 2-methylpentyl group Chemical group 0.000 description 1
- 125000006024 2-pentenyl group Chemical group 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-M 3-Methylbutanoic acid Natural products CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 description 1
- 125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 1
- 125000006041 3-hexenyl group Chemical group 0.000 description 1
- 125000003542 3-methylbutan-2-yl group Chemical group [H]C([H])([H])C([H])(*)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000005917 3-methylpentyl group Chemical group 0.000 description 1
- 125000006042 4-hexenyl group Chemical group 0.000 description 1
- 125000006043 5-hexenyl group Chemical group 0.000 description 1
- OSDWBNJEKMUWAV-UHFFFAOYSA-N Allyl chloride Chemical compound ClCC=C OSDWBNJEKMUWAV-UHFFFAOYSA-N 0.000 description 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 description 1
- 238000003512 Claisen condensation reaction Methods 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 238000007171 acid catalysis Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical compound BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 description 1
- 238000005937 allylation reaction Methods 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 150000003983 crown ethers Chemical class 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- HWYQPOCXHSDIHD-UHFFFAOYSA-N ethyl 4-chloro-2-propan-2-ylpent-4-enoate Chemical compound CCOC(=O)C(C(C)C)CC(Cl)=C HWYQPOCXHSDIHD-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229940042795 hydrazides for tuberculosis treatment Drugs 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- YNESATAKKCNGOF-UHFFFAOYSA-N lithium bis(trimethylsilyl)amide Chemical compound [Li+].C[Si](C)(C)[N-][Si](C)(C)C YNESATAKKCNGOF-UHFFFAOYSA-N 0.000 description 1
- UBJFKNSINUCEAL-UHFFFAOYSA-N lithium;2-methylpropane Chemical compound [Li+].C[C-](C)C UBJFKNSINUCEAL-UHFFFAOYSA-N 0.000 description 1
- UPTHEJMPARMRJA-UHFFFAOYSA-N lithium;bis(1-adamantyl)azanide Chemical compound [Li+].C1C(C2)CC(C3)CC2CC13[N-]C(C1)(C2)CC3CC2CC1C3 UPTHEJMPARMRJA-UHFFFAOYSA-N 0.000 description 1
- WGOPGODQLGJZGL-UHFFFAOYSA-N lithium;butane Chemical compound [Li+].CC[CH-]C WGOPGODQLGJZGL-UHFFFAOYSA-N 0.000 description 1
- AHNJTQYTRPXLLG-UHFFFAOYSA-N lithium;diethylazanide Chemical compound [Li+].CC[N-]CC AHNJTQYTRPXLLG-UHFFFAOYSA-N 0.000 description 1
- RZYQVFNZQTZPKQ-UHFFFAOYSA-N lithium;ditert-butylazanide Chemical compound [Li+].CC(C)(C)[N-]C(C)(C)C RZYQVFNZQTZPKQ-UHFFFAOYSA-N 0.000 description 1
- CETVQRFGPOGIQJ-UHFFFAOYSA-N lithium;hexane Chemical compound [Li+].CCCCC[CH2-] CETVQRFGPOGIQJ-UHFFFAOYSA-N 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000010327 methods by industry Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000001298 n-hexoxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- UYYCVBASZNFFRX-UHFFFAOYSA-N n-propan-2-ylcyclohexanamine Chemical compound CC(C)NC1CCCCC1 UYYCVBASZNFFRX-UHFFFAOYSA-N 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001979 organolithium group Chemical group 0.000 description 1
- 150000002905 orthoesters Chemical class 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- UKODFQOELJFMII-UHFFFAOYSA-N pentamethyldiethylenetriamine Chemical compound CN(C)CCN(C)CCN(C)C UKODFQOELJFMII-UHFFFAOYSA-N 0.000 description 1
- 125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- IUBQJLUDMLPAGT-UHFFFAOYSA-N potassium bis(trimethylsilyl)amide Chemical compound C[Si](C)(C)N([K])[Si](C)(C)C IUBQJLUDMLPAGT-UHFFFAOYSA-N 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000003548 sec-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- WRIKHQLVHPKCJU-UHFFFAOYSA-N sodium bis(trimethylsilyl)amide Chemical compound C[Si](C)(C)N([Na])[Si](C)(C)C WRIKHQLVHPKCJU-UHFFFAOYSA-N 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
- C07C51/363—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/08—Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides with the hydroxy or O-metal group of organic compounds
Definitions
- the present invention relates to a process for the preparation of substituted in 2-position carboxylic acids by alkylation of the corresponding dianions of the carboxylic acid used.
- the invention further relates to a process for the preparation of the corresponding carboxylic acid derivatives, especially the corresponding carboxylic esters by esterification of the produced ⁇ -substituted carboxylic acids.
- Alkylation of carboxylic acid esters by deprotonation with strong bases and trapping of the metal enolate with electrophiles is an important transformation of organic synthetic chemistry.
- Deprotonation is typically conducted at very low temperatures, often at -78 ° C. In order to avoid unwanted side reactions, especially the Claisen condensation, it is customarily allowed to warm up to room temperature only after addition of the electrophile, as described by W. Dai, for example. in J. Org. Chem. 1993, 58, 1900-1908.
- DMPU dimethylpropyleneurea
- HMPT hexamethylphosphoric acid triamide
- the carboxylic acids selected as starting materials can also be converted into the corresponding dianions by addition of a sufficient amount of a strong base and then alkylated.
- This synthesis variant is also carried out to obtain satisfactory yields, usually in the presence of complexing agents such as HMPT or DMPU.
- 2-substituted isovaleric acids are in principle accessible in this way. They represent important intermediates for the production of active pharmaceutical ingredients.
- WO 01/09079 discloses a process for the preparation of 2-alkyl-5-halogen-pent-4-enecarboxylic acids and their acid derivatives such as their esters by alkylation of the corresponding ester enolates with allyl halides.
- the reaction of ethyl isovalerate with lithium diisopropylamide to give the corresponding ester enolate and subsequent reaction with trans-1,3-dichloropropene is described by way of example.
- the reaction is carried out in the presence of potassium iodide and DMPU as cosolvent at -20 ° C.
- US 4,492,799 discloses a process for the preparation of ethyl 4-chloro-2-isopropyl-4-pentenoate by deprotonation of ethyl isovalerate with lithium diisopropylpropamide and subsequent reaction with 2,3-dichloro-1-propene at temperatures from -78 ° C to -30 ° C C.
- the target compound was obtained in a yield of 46% of theory receive.
- the conversion of a carboxylic acid into its dianion followed by allylation is described schematically.
- the object underlying the present invention was to provide a process for the one-stage preparation of 2-substituted carboxylic acids which can be carried out under conditions which are as advantageous as possible in the process, especially at advantageously realizable temperatures and avoiding undesired additives or solvents.
- the formation of undesirable by-products should be avoided as far as possible.
- R 1 is hydrogen or unbranched, branched or cyclic C 1 to C 6 alkyl
- R 2 is unbranched or branched C 1 to C 6 alkyl or C 1 to C 6 alkenyl or
- R 1 has the same meaning as in formula (I),
- R 2 has the same meaning as in formula (I) and
- X represents chlorine, bromine, iodine, triflate, tosylate or mesylate.
- radical R 1 is hydrogen or straight-chain, branched or cyclic C 1 - to C 6 -alkyl and the radical R 2 is unbranched or branched C 1 - to C 6 -alkyl or C 2 - to C 6 -alkenyl or benzyl
- the said Radicals may have one or more identical or different substituents selected from the group of the substituents chlorine, bromine, iodine, alkoxy, thioalkyl, dialkylamino, diarylamino and aryl.
- C 1 to C 6 alkyl are to be understood as meaning alkyl radicals having 1 to 6 carbon atoms, such as, for example: methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl, 1, 1-dimethylethyl, Pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 1-ethylpropyl, hexyl, 1, 1-dimethylpropyl, 1, 2-dimethylpropyl, 1-methylpentyl, 2-methylpentyl, 3 Methylpentyl, 4-methylpentyl,
- C2- to C ⁇ -alkenyl in the context of the present invention represents a mono- or polyethylenically unsaturated radical having 2 to 6 carbon atoms, such as, for example: ethenyl, 1-propenyl, 2-propenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, 1-hexenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl and 5-hexenyl.
- the radicals mentioned can, if possible, be present in each case in the cis or trans or the E or Z configuration with respect to the double bonds present.
- radicals mentioned may contain one or more, usually 1 or 2, identical or different substituents selected from the group of the substituents chlorine, bromine, iodine, alkoxy, thioalkyl, dialkylamino, diarylamino and aryl, preferably chlorine , exhibit.
- alkoxy is preferably a C 1 - to C 6 -alkyl radical bonded via an oxygen atom, as described above, particularly preferably methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, sec-butoxy, tert-butoxy, n-pentoxy or n-hexoxy.
- thioalkyl is preferably a bonded via a sulfur, as described above d- to C ⁇ -alkyl radical.
- dialkylamino is taken to mean amino substituents having two identical or different alkyl radicals, preferably as described above, to C 5 -alkyl radicals, for example dimethylamino or diethylamino.
- aryl denotes in the context of the present invention an aryl radical having 6 to 14 carbon atoms, preferably optionally substituted phenyl.
- diarylamino is understood to mean an amino substituent having two identical or different aryl radicals.
- radicals R 1 may be mentioned: isopropyl, isobutyl, tert. Butyl, sec. Butyl, most preferably isopropyl.
- Preferred radicals R 2 according to the invention are chlorine-substituted propenyl radicals, for example 3-chloropropen-1-yl, 2-chloropropen-1-yl, 1-chloropropen-3-yl, 2-chloropropene-3 Particularly preferred is trans-1-chloro-propen-3-yl.
- the starting compounds to be used according to the invention are compounds of the formula (II)
- R 1 has the same meaning as for the desired target compound of the formula (I).
- R 1 in formula (II) is unbranched or branched Cr to Ce-alkyl.
- step a) of the process according to the invention the starting compounds of the formula (I) are reacted with from about 1.8 to about 2.5 molar equivalents, preferably from about 1.9 to about 2.2 molar equivalents, more preferably about 2.0 mol equivalents (based on the amount of acid to be deprotonated of the formula (M)) base, preferably with the stated amounts of a strong base to.
- the term strong base means those bases which are capable, ie strong enough, of converting a carboxylic acid into its corresponding dianion (ie into the enolate of the corresponding carboxylate), in particular those whose conjugated acid has a pK a value of about 26 or above, preferably about 30 or above, and more preferably having a pK a of from about 35 to about 50, especially to about 45, such as lithium alkyls such as methyllithium, butyl lithium, phenyllithium, alkali metals such as lithium, sodium or potassium, or amine bases such as, for example, potassium hexamethyldisilazide, sodium hexamethyldisilazide, lithium hexamethyldisilazide, lithium diisopropylamide, lithium diethylamide, lithium di-tert-butylamide, lithium di-adamantylamide, lithium 2,2,6,6-tetramethylethylpiperidide.
- the carboxylic acid of the formula (II) is reacted according to step a) first by treatment with a base, preferably with about 0.8 to about 1.2 mol equivalents, more preferably with about 1 molar equivalent of a weak base capable of deprotonating a carboxylic acid group into the corresponding carboxylate of the formula (IV)
- the amount of strong base to be used is expediently chosen so that the carboxylic acid used or the intermediate carboxylate of the formula (IV) is converted as completely as possible into the dianion, ie the enolate of the carboxylate.
- about 0.8 to about 1.3 molar equivalents preferably from about 0.9 to about 1.1 molar equivalents, more preferably 1 molar equivalent of the selected strong base.
- Preferred strong bases according to the invention are metallated dialkylamines of the formula (V)
- M is lithium, sodium or potassium, preferably lithium and the radicals R 3 and R 4 are identical or different and are an unbranched, branched or cyclic C 1 to C 6 alkyl radical or a trialkylsilyl radical, for example trimethylsilyl.
- metallated, preferably lithiated, dialkylamines can be prepared by methods known per se to the person skilled in the art, for example by treatment of a corresponding dialkylamine, such as, for example, diisopropylamine, diisobutylamine or isopropylcyclohexylamine, with a suitable lithium alkyl such as, for example,
- Butyllithium, s-butyllithium, tert-butyllithium, n-hexyllithium, methyllithium or phenyl lithium Such processes are described in detail, for example, in "The Practice of the Organic Chemist", Gattermann, Wieland, newly edited by T. Wieland and W. Sucrow, 43rd ed., Berlin-New York, Walter de Gruyter Furthermore, solutions of such bases
- a particularly preferred strong base according to the invention is lithium diisoproylamine (LDA).
- the reaction according to step a) of the present invention is advantageously carried out by preparing a solution of the chosen strong base, preferably the chosen lithiated dialkylamine in a suitable solvent such as tetrahydrofuran, dioxane, dimethoxyethane or other cyclic or acyclic ethers. This is usually done at temperatures of about -80 ° C to about 0 ° C, preferably from about -60 ° C to about 0 ° C, more preferably about -40 ° C to about 0 ° C, and most preferably about -20 ° C to about 0 ° C by adding the selected organolithium reagent to the selected dialkylamine.
- a suitable solvent such as tetrahydrofuran, dioxane, dimethoxyethane or other cyclic or acyclic ethers.
- the selected starting compound of the formula (I) is then usually added to the prepared solution of the strong base.
- the addition and the subsequent reaction of the carboxylic acid of the formula (I) with the selected strong base is preferably carried out at temperatures of about -20.degree. C. to about 0.degree.
- a dropping time of usually about 10 minutes to about 1 hour the formation of the carboxylic acid dione is usually rapid, usually after about 2 hours, often after about 1 hour.
- step b) of the process according to the invention the intermediate product or product mixture obtained in step a) is reacted with a compound of the formula (III) R 2 - X (III)
- radical R 2 has the same meaning as in the target compound of the formula (I) and X is chlorine, bromine or iodine, triflate, tosylate or mesylate, preferably chlorine.
- the compounds of the formula (III) are alkyl or alkenyl halides or triflates, mesylates or tosylates having up to 6 carbon atoms or benzyl halides or triflates, methylates or tosylates, each of which is further as described for the radical R 2 may have substituents.
- Preferred compounds of the formula (III) according to the invention are allyl halides, in particular allyl halides such as, for example, allyl chloride, allyl bromide, 1,3-dichloropropene, 1,2-dichloropropene, 3-chloroallyl mesylate, 3-chloroallyl triflate, 3-chloroallyl tosylate, particularly preferably trans-1 , 3-dichloropropene.
- allyl halides such as, for example, allyl chloride, allyl bromide, 1,3-dichloropropene, 1,2-dichloropropene, 3-chloroallyl mesylate, 3-chloroallyl triflate, 3-chloroallyl tosylate, particularly preferably trans-1 , 3-dichloropropene.
- step b) is advantageously carried out by adding the selected compound of the formula (III) to the solution of the double-deprotonated carboxylic acid prepared in step a) preferably at a temperature of about -20.degree. C. to about 0.degree , It may be advantageous to use the selected compound of the formula (III) in a slight molar excess with respect to the carboxylic acid dianion or the starting compound of the formula (M), especially in a molar ratio of from about 1: 1 to about 2: 1 about 1.05 to 1 to about 1.3: 1.
- the formation of the desired product of the formula (I) in the abovementioned temperature range is usually completed after about 1 to about 24 hours, often after about 3 to about 6 hours.
- the products or product mixtures obtained can subsequently be worked up, isolated or further purified by methods known to those skilled in the art.
- the reaction according to the invention in step b) can be successfully carried out while substantially avoiding complexing agents or co-solvents such as hexamethylphosphoric triamide (HMPT), dimethylpropylene urea (DMPU), tetramethylethylenediamine (TMEDA), pentamethyldiethylenetriamine, crown ethers, for example.
- HMPT hexamethylphosphoric triamide
- DMPU dimethylpropylene urea
- TEDA tetramethylethylenediamine
- pentamethyldiethylenetriamine crown ethers
- B. 15-crown-5, DMF, potassium tert-butoxide can be performed.
- the reaction is preferably carried out in the presence of up to about 0.25 equivalents, more preferably of up to 0.2 and more preferably of up to about 0.1 equivalents of the particular complexing agent, based on the molar amount of base used.
- the reaction according to step a) and / or step b) is carried out without addition, ie in the absence of complexing agents or cosolvents, particularly preferably in the absence of HMPT.
- the present invention relates to a process for the preparation of compounds of the formula (Ia)
- R 1 ' may have the same meanings as R 1 in formula (I), preferably isopropyl and Z is chlorine, bromine or iodine, preferably chlorine, comprising the steps
- R 1 has the same meaning as in formula (Ia), with 1, 8 to 2.5 mol equivalents of a base as described above and
- Z has the same meaning as in formula (Ia) and Z 'may be the same or different from Z and chlorine, bromine or iodine, preferably chlorine.
- ⁇ -substituted carboxylic acids of the formula (I) or (Ia) obtainable by the process according to the invention can in turn be esterified by methods known to the person skilled in the art, for example by acid catalysis in the presence of an alcohol.
- carboxylic acids which can be prepared according to the invention are also suitable for the preparation of any further carboxylic acid derivatives such as, for example, carboxylic acid amides, hydrazides, azides, nitriles, orthoesters and carboxylic acid halides.
- carboxylic acid derivatives such as, for example, carboxylic acid amides, hydrazides, azides, nitriles, orthoesters and carboxylic acid halides.
- derivatizations are known to the person skilled in the art and are described, for example, in Organikum, Organisch-Chemisches Grundpraktikum, 20th Edition, Wiley-VCH Verlag Weinheim, Chapter 7.
- the present invention therefore also relates to a process for the preparation of carboxylic acid derivatives of the formula (VI)
- R 1 , R 2 may have the meanings given in formula (I) and
- R 5 is a straight-chain, branched and / or cyclic C 1 - to C 12 -alkyl radical or C 7 - to C 12 -aralkyl radical and
- R 6, R 7 are independently hydrogen or a straight-chain, branched and / or cyclic d- to Ci2-alkyl or C7 to C12 aralkyl group mean
- the present invention relates to processes for the preparation of carboxylic acid esters of the formula (VII)
- R 1 , R 2 may have the meanings given in formula (I) and
- R 5 represents a straight-chain, branched and / or cyclic C 1 - to C 12 -alkyl radical or C 7 - to C 12 -aralkyl radical
- C 1 - to C 12 -alkyl denotes a straight-chain or branched alkyl radical having 1 to 12 carbon atoms, for example as mentioned above for C 1 - to C 6 -alkyl and furthermore also heptyl, octyl, nonyl, decyl, dodecyl.
- Cj- to C12-aralkyl is an attached via an alkyl radical having at least one carbon atom
- Phenyl for example benzyl, 1-phenylethyl or 2-phenylethyl.
- Halogen is fluorine, chlorine, bromine or iodine, preferably fluorine, chlorine or bromine. Accordingly, the process according to the invention provides attractive access to carboxylic acids substituted in the 2-position and their esters starting from the usually readily accessible unsubstituted carboxylic acids.
- a particular advantage of the method according to the invention is that it can be carried out in procedurally and economically advantageous conditions, especially while avoiding low temperatures and while avoiding additional procedurally and toxicologically problematic reagents.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La présente invention concerne un procédé de production d'acides carboxyliques substitués en position 2 par l'alkylation des dianions correspondants de l'acide carboxylique utilisé. Cette invention concerne également un procédé de production des dérivés d'acides carboxyliques correspondants, en particulier des esters d'acides carboxyliques correspondants par l'estérification des acides carboxyliques a-substitués produits.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005047450.0 | 2005-09-30 | ||
DE102005047450 | 2005-09-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2007036491A1 true WO2007036491A1 (fr) | 2007-04-05 |
Family
ID=37686167
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2006/066641 WO2007036491A1 (fr) | 2005-09-30 | 2006-09-22 | Procede de production d'acides carboxyliques alpha-substitues |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2007036491A1 (fr) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5047534A (en) * | 1990-03-26 | 1991-09-10 | Merrell Dow Pharmaceuticals Inc. | Selective adenosine receptor agents |
WO2001009079A1 (fr) * | 1999-07-29 | 2001-02-08 | Speedel Pharma Ag | Acides alkyle-5-halogene-pent-4-ene-carboxyliques et leur preparation |
-
2006
- 2006-09-22 WO PCT/EP2006/066641 patent/WO2007036491A1/fr active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5047534A (en) * | 1990-03-26 | 1991-09-10 | Merrell Dow Pharmaceuticals Inc. | Selective adenosine receptor agents |
WO2001009079A1 (fr) * | 1999-07-29 | 2001-02-08 | Speedel Pharma Ag | Acides alkyle-5-halogene-pent-4-ene-carboxyliques et leur preparation |
Non-Patent Citations (5)
Title |
---|
KUEHNE M E ET AL: "STUDIES IN BIOMIMETIC ALKALOID SYNTHESES 8. TOTAL SYNTHESES OF THE 14 CARBON EPIMERIC HYDROXY VINCADIFFORMINES TABERSONINE A HYDROXYMETHYL-D NORVINCADIFFORMINE AND THE 20 CARBON EPIMERIC PANDOLINES", JOURNAL OF ORGANIC CHEMISTRY, vol. 47, no. 7, 1982, pages 1335 - 1343, XP002421004, ISSN: 0022-3263 * |
MACPHEE J-A ET AL: "Steric effects in synthesis - steric limits to the alkylation of nitriles and carboxylic acids", TETRAHEDRON, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 36, no. 6, 1980, pages 775 - 777, XP002421050, ISSN: 0040-4020 * |
NEVALAINEN M ET AL: "Total synthesis of nor-1,6-germacradien-5-ols", JOURNAL OF ORGANIC CHEMISTRY 08 MAR 2002 UNITED STATES, vol. 67, no. 5, 8 March 2002 (2002-03-08), pages 1554 - 1560, XP002421005, ISSN: 0022-3263 * |
PADWA A ET AL: "LIGAND EFFECTS ON DIRHODIUM (II) CARBENE REACTIVITIES HIGHLY EFFECTIVE SWITCHING BETWEEN COMPETITIVE CARBENOID TRANSFORMATIONS", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, AMERICAN CHEMICAL SOCIETY, WASHINGTON, DC, US, 1993, pages 8669 - 8680, XP000667320, ISSN: 0002-7863 * |
PFEFFER P E ET AL: "Alpha-Anions of Carboxylic Acids", JOURNAL OF ORGANIC CHEMISTRY, AMERICAN CHEMICAL SOCIETY. EASTON, US, vol. 37, no. 3, 1972, pages 451 - 458, XP002421003, ISSN: 0022-3263 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0623575A1 (fr) | Procédé pour la préparation de cétones | |
EP1682527B1 (fr) | Procede de fabrication de statines | |
EP1197483B1 (fr) | Procédé pour la réduction catalitique de composés alcyniques | |
EP0429998B1 (fr) | Procédé pour la préparation d'alcools partiellement fluorés | |
DE3917737A1 (de) | Verfahren zur herstellung von ungesaettigten alkoholen | |
DE69807700T2 (de) | Herstehhung von alkalimetal diarylphosphid und cycloalkyldiarylphosphine | |
DE69009369T2 (de) | Verfahren zur Herstellung von Alkynylverbindungen. | |
EP2050754A1 (fr) | Procédé de fabrication d'alkyle-méthoxyméthyle-triméthylsilanylméthylamines | |
DE69520077T2 (de) | Oxotitankomplexe verwendbar als Katalysatoren für assymetrische Reaktionen insbesondere zur Herstellung von beta-hydroxy-Ketonen oder alpha-hydroxy-Carbonsäureestern | |
WO2007036491A1 (fr) | Procede de production d'acides carboxyliques alpha-substitues | |
WO2007028714A2 (fr) | Procede de production d'acides carboxyliques substitues en position 2 | |
WO2011113925A2 (fr) | Carbonylation de composés organiques de zinc | |
DE69915430T2 (de) | Verfahren zur Herstellung halogenierter Phenylmalonaten | |
EP0031875B1 (fr) | Procédé pour la préparation de dérivés de cyclohexène | |
DE60225199T2 (de) | Verfahren zur Herstellung von Michael-addukten | |
DE3018575C2 (de) | Verfahren zur Herstellung eines Alkalimetallsalzes einer 3-(17β-Hydroxyandrosten-3-on-acetal-17α-yl)-propiolsäure | |
DE69901632T2 (de) | Verfahren zur Herstellung von Cyclopropylacetylenderivaten | |
EP2657216B1 (fr) | Procédé de basculement du farnésol au nérolidol en présence d'alpha-bisabolol | |
DE102006060949A1 (de) | Verfahren zur Herstellung von Menthylderivaten | |
EP0605607B1 (fr) | Preparation d'enolates manganeux et ses applications | |
EP1666447B1 (fr) | Procédé de préparation de dérives d'acides carboxyliques d'alpha, alpha-dialkyl, alpha-hydroxymethyl | |
DE2651085A1 (de) | Neue hydroximsaeureester und verfahren zu ihrer herstellung | |
DE10047111A1 (de) | Verfahren zur Herstellung von DELTA·1·-Pyrrolinen | |
DE2403631A1 (de) | 3-methyl-5-(3-methyl-3-hydroxybutyl)-3cyclohexencarboxaldehyd, verfahren zu seiner herstellung und seine verwendung als riechstoff | |
WO2004094383A1 (fr) | Procede pour produire des aldehydes de nicotine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06793755 Country of ref document: EP Kind code of ref document: A1 |